Biocartis raises EUR 10 million

Molecular diagnostics company Biocartis S.A. (Lausanne, Switzerland) raised EUR 10 million ($14.7 million) in a series A round led by Aescap. Biovest; KBC Private Equity; Advent; and Benaruca also par...